ReviewPharmaceuticals (Basel, Switzerland)2025

Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review.

Zineddine Belabaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.